CN102961523A - Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis - Google Patents
Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis Download PDFInfo
- Publication number
- CN102961523A CN102961523A CN2012104160176A CN201210416017A CN102961523A CN 102961523 A CN102961523 A CN 102961523A CN 2012104160176 A CN2012104160176 A CN 2012104160176A CN 201210416017 A CN201210416017 A CN 201210416017A CN 102961523 A CN102961523 A CN 102961523A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- rhizoma
- hyperlipemia
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis, belongs to the technical field of traditional Chinese medicine, and aims to solve the technical problem by providing a traditional Chinese medicine capable of effectively treating hyperlipidemia, and with less side effects and low cost. A technical scheme is as below: a traditional Chinese medicine for treating hyperlipemia and arteriosclerosis is composed of the following bulk drugs, by weight: 6-12 parts of leech, 9-20 parts of Pollen Typhae, 20-60 parts of rhizoma alismatis, 20-50 parts of hawthorn, 10-30 parts of raw fleece-flower root, 15-30 parts of cassia seed, 12-15 parts of Polygonum cuspidatum, 20-40 parts of the root of red-rooted salvia, 15-30 parts of kelp, 15-30 parts of seaweed, 12-50 parts of root of common peony, 12-20 parts of Ligusticum wallichii, and 6-12 parts of safflower. The preparation can be a decoction, a pill, an electuary or a capsule, and can be used for treating hyperlipemia and arteriosclerosis.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of.
Background technology
Hyperlipemia is that one or more lipids are higher than normally in the blood plasma because lipid metabolism or running make unusually.Can show as hypercholesterolemia, hypertriglyceridemia or both have concurrently, i.e. combined hyperlipidemia familial.Except constitutional, namely outside the heritability disorders of lipid metabolism disease, be common in the bad diabetes of control, drink, hypothyroidism, nephrotic syndrome, dialysis, renal transplantation, biliary obstruction, oral contraceptive etc.Dyslipidemia and the heart, cerebrovascular disease, especially closely related with generation, the development of coronary heart disease.China as developing country, the rapid growth period of still being in hyperlipidemia, its coronary heart disease that causes, cerebrovascular, metabolic disturbance diseases bring huge financial burden and burden on society to broad masses of the people and country, and the control dyslipidemia becomes one of important content of slow sick preventing and controlling.
At present, mainly be to add with serum regulating drug on the basis of Diet Therapy to treat for the Therapeutic Method of hyperlipemia.Be oral hydroxyl methylglutaric acid list acyl coenzyme A HMG-CoA Reductase Inhibitor HMG-CoA, claim again statins, or clofibrate and phenoxy acetic acid class medicine, claim again shellfish special class medicine, etc., all there is the liver enzyme to raise, severe patient can cause the side effect such as rhabdomyolysis, acute renal failure, and easily drug withdrawal knock-on; Lipid-regulation medicine is mostly expensive, and patient is difficult to comply with for a long time.
Summary of the invention
The present invention overcomes the deficiency that prior art exists, and technical problem to be solved can effectively be treated hyperlipemia for providing a kind of, few side effects, the Chinese medicine for the treatment of hyperlipemia with low cost.
In order to solve the problems of the technologies described above, the technical solution used in the present invention is: a kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of is the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 6-12 Pollen Tyjphae: 9-20 Rhizoma Alismatis: 20-60 Fructus Crataegi: 20-50
Radix Polygoni Multiflori: 10-30 Semen Cassiae: 15-30 Rhizoma Polygoni Cuspidati: 12-15 Radix Salviae Miltiorrhizae: 20-40
Thallus Laminariae (Thallus Eckloniae): 15-30 Sargassum: 15-30 Radix Paeoniae Rubra: 12-50 Rhizoma Chuanxiong: 12-20
Flos Carthami: 6-12.
Described medicament is decoction, or is pill, or is electuary, or is capsule.
As preferably, a kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of is the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 10-12 Pollen Tyjphae: 12-18 Rhizoma Alismatis: 35-45 Fructus Crataegi: 25-35
Radix Polygoni Multiflori: 15-25 Semen Cassiae: 18-23 Rhizoma Polygoni Cuspidati: 12-13 Radix Salviae Miltiorrhizae: 25-35
Thallus Laminariae (Thallus Eckloniae): 18-22 Sargassum: 18-22 Radix Paeoniae Rubra: 30-35 Rhizoma Chuanxiong: 15-17
Flos Carthami: 8-11.
Preferred plan the most, a kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of is the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 12 Pollen Tyjphae: 15 Rhizoma Alismatis: 40 Fructus Crataegi: 30
Radix Polygoni Multiflori: 20 Semen Cassiaes: 20 Rhizoma Polygoni Cuspidati: 12 Radix Salviae Miltiorrhizaes: 30
Thallus Laminariae (Thallus Eckloniae): 20 Sargassums: 20 Radix Paeoniae Rubra: 30 Rhizoma Chuanxiongs: 20
Flos Carthami: 10.
Among the present invention, Hirudo: anticoagulation is arranged, improve microcirculatory effect; Pollen Tyjphae: but blood fat reducing and atherosclerosis; Rhizoma Alismatis: can reduce serum total cholesterol and triacylglycerol content, slow down atherosclerosis; Fructus Crataegi: have blood vessel dilating, heart tonifying, increase coronary flow, improve the effect of heart vigor, stimulating central nervous system system, blood fat reducing, blood pressure and cholesterol, vessel softening; Radix Polygoni Multiflori: can expand the coronary artery of heart, blood fat reducing promotes erythrocytic generation; Semen Cassiae: the effect of cathartic, blood pressure lowering, blood fat reducing is arranged; Rhizoma Polygoni Cuspidati: but blood fat reducing; Radix Salviae Miltiorrhizae: have heart tonifying, blood vessel dilating, prolongation clotting time and improve microcirculatory effect; Thallus Laminariae (Thallus Eckloniae): but blood pressure lowering, blood sugar lowering, blood fat reducing, anticoagulation; Sargassum: but blood fat reducing; Radix Paeoniae Rubra: have anticoagulation, antiplatelet aggregation, blood fat reducing and arteriosclerosis effect; Rhizoma Chuanxiong: blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression; Flos Carthami: promoting blood circulation to restore menstrual flow has the effect of blood vessel dilating, anticoagulation and blood fat reducing.
With said herbal medicine according to formula compatibility of the present invention, both can blood fat reducing, again can arteriosclerosis, reduce the cardiovascular and cerebrovascular vessel morbidity, and non-evident effect.
The specific embodiment
After medicine of the present invention configures according to component, can be fried into decoction according to conventional method and take, every day potion, decocting twice, sooner or later sub-service, the patient with severe symptoms can every day two doses.Also can manufacture medicine pill, instant particles as Chinese medicine is taken, can also make capsule and take.
The present invention is through clinical practice, and general about 15 days take effect, and chemical examination blood fat projects change, and normal about one month, the Vascular Ultrasonography carotid intimal medial thickness obviously lowers after 60 days, illustrate this invention can blood fat reducing, arteriosclerosis.
Embodiment one
A kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of is the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 6g Pollen Tyjphae: 15g Rhizoma Alismatis: 40g Fructus Crataegi: 40g
Radix Polygoni Multiflori: 10g Semen Cassiae: 20g Rhizoma Polygoni Cuspidati: 12g Radix Salviae Miltiorrhizae: 30g
Thallus Laminariae (Thallus Eckloniae): 15g Sargassum: 15g Radix Paeoniae Rubra: 30g Rhizoma Chuanxiong: 12g
Flos Carthami: 12g.
Embodiment two
A kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of is the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 12g Pollen Tyjphae: 20g Rhizoma Alismatis: 60g Fructus Crataegi: 50g
Radix Polygoni Multiflori: 20g Semen Cassiae: 30g Rhizoma Polygoni Cuspidati: 15g Radix Salviae Miltiorrhizae: 40g
Thallus Laminariae (Thallus Eckloniae): 30g Sargassum: 30g Radix Paeoniae Rubra: 40g Rhizoma Chuanxiong: 12g
Flos Carthami: 12g.
Embodiment three
A kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of is the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 12g Pollen Tyjphae: 15g Rhizoma Alismatis: 40g Fructus Crataegi: 30g
Radix Polygoni Multiflori: 20g Semen Cassiae: 20g Rhizoma Polygoni Cuspidati: 12g Radix Salviae Miltiorrhizae: 30g
Thallus Laminariae (Thallus Eckloniae): 20g Sargassum: 20g Radix Paeoniae Rubra: 30g Rhizoma Chuanxiong: 20g
Flos Carthami: 10g.
Embodiment four
A kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of is the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 10g Pollen Tyjphae: 9g Rhizoma Alismatis: 20g Fructus Crataegi: 20g
Radix Polygoni Multiflori: 30g Semen Cassiae: 15g Rhizoma Polygoni Cuspidati: 13g Radix Salviae Miltiorrhizae: 20g
Thallus Laminariae (Thallus Eckloniae): 18g Sargassum: 22g Radix Paeoniae Rubra: 50g Rhizoma Chuanxiong: 15g
Flos Carthami: 6g.
Embodiment five
A kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of is the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 11g Pollen Tyjphae: 12g Rhizoma Alismatis: 35g Fructus Crataegi: 25g
Radix Polygoni Multiflori: 15g Semen Cassiae: 18g Rhizoma Polygoni Cuspidati: 14g Radix Salviae Miltiorrhizae: 25g
Thallus Laminariae (Thallus Eckloniae): 19g Sargassum: 18g Radix Paeoniae Rubra: 12g Rhizoma Chuanxiong: 16g
Flos Carthami: 8g.
Embodiment six
A kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of is the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 9g Pollen Tyjphae: 18g Rhizoma Alismatis: 45g Fructus Crataegi: 35g
Radix Polygoni Multiflori: 25g Semen Cassiae: 23g Rhizoma Polygoni Cuspidati: 15g Radix Salviae Miltiorrhizae: 35g
Thallus Laminariae (Thallus Eckloniae): 22g Sargassum: 21g Radix Paeoniae Rubra: 35g Rhizoma Chuanxiong: 17g
Flos Carthami: 11g.
Case one
The field, the man, 45 years old, because of xerostomia in nearly January, polydipsia was gone to a doctor.Chemical examination T-CHOL 6.02mmol/L, triglyceride 3.14mmol/L, low density lipoprotein, LDL 3.60, fasting glucose 6.20mmol/L, after the meal two hours blood glucose 8.70mmol/L, glycolated hemoglobin 4.52%, glutamate pyruvate transaminase 62.28U/L, transglutaminase 58.36U/L, carbamide 3.94mmol/L, creatinine 106.55mmol/L is diagnosed as combined hyperlipidemia familial.
Take by embodiment one preparation Chinese medicine of the present invention, every day potion, decocting twice, sooner or later sub-service.After taking 30 doses, the check result of laboratory test is T-CHOL 4.98mmol/L, triglyceride 1.17mmol/L, low density lipoprotein, LDL 2.60, fasting glucose 4.12mmol/L, two hours blood glucose 7.80mmol/L after the meal, glycolated hemoglobin 4.38%, glutamate pyruvate transaminase 40.13U/L, transglutaminase 38.09U/L, carbamide 5.64mmol/L, creatinine 89.75mmol/L.
Case two
What certain, man, 57 years old, drink Chinese liquor every day more than 500 milliliters, abdominal circumference 110cm, night the paroxysmal sleep apnea, chemical examination when medical: T-CHOL 8.17mmol/L, triglyceride 7.04mmol/L, low density lipoprotein, LDL 5.20, fasting glucose 5.26mmol/L, two hours blood glucose 11.34mmol/L after the meal, glycolated hemoglobin 6.3%, glutamate pyruvate transaminase 89.54U/L, transglutaminase 112.34U/L, carbamide 7.64mmol/L, creatinine 90.75mmol/L.Abdominal B type ultrasonography is shown severe fatty liver, the ultrasonic carotid intimal medial thickness 1.4mm that shows of Cervical Vessels.This patient is the improper severe hyperlipemia that causes of life style, abnormal liver function, fatty liver, arteriosclerosis.
Advise patient's mode of making the life better, and take by embodiment two preparations Chinese medicine of the present invention, every day potion, decocting twice, sooner or later sub-service.After taking 30 doses, the check result of laboratory test is T-CHOL 6.08mmol/L, triglyceride 2.06mmol/L, low density lipoprotein, LDL 3.70, fasting glucose 5.13mmol/L, two hours blood glucose 7.28mmol/L after the meal, glycolated hemoglobin 5.91%, glutamate pyruvate transaminase 60.23U/L, transglutaminase 77.13U/L, carbamide 6.04mmol/L, creatinine 78.42mmol/L, abdominal circumference is reduced to 98cm, and the carotid ultrasound carotid intimal medial thickness is 1.3mm.Continue to take by the medicine pill of the present invention of embodiment two preparation preparations 1 month chemical examination check: T-CHOL 5.19mmol/L, triglyceride 1.71mmol/L, low density lipoprotein, LDL 2.99, fasting glucose 5.47mmol/L, two hours blood glucose 6.70mmol/L after the meal, glycolated hemoglobin 4.52%, glutamate pyruvate transaminase 40.07U/L, transglutaminase 44.68U/L, carbamide 5.73mmol/L, creatinine 68.02mmol/L, abdominal circumference is reduced to 89cm, and the carotid ultrasound carotid intimal medial thickness is 1.14mm.Continued to take above-mentioned medicine pill one month, bounce-back is checked in drug withdrawal after half a year.
Claims (4)
1. treat hyperlipemia, arteriosclerotic Chinese medicine for one kind, it is characterized in that: be the medicament of being made by the raw material of following weight portion proportioning:
Hirudo: 6-12 Pollen Tyjphae: 9-20 Rhizoma Alismatis: 20-60 Fructus Crataegi: 20-50
Radix Polygoni Multiflori: 10-30 Semen Cassiae: 15-30 Rhizoma Polygoni Cuspidati: 12-15 Radix Salviae Miltiorrhizae: 20-40
Thallus Laminariae (Thallus Eckloniae): 15-30 Sargassum: 15-30 Radix Paeoniae Rubra: 12-50 Rhizoma Chuanxiong: 12-20
Flos Carthami: 6-12.
2. a kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of according to claim 1, it is characterized in that: the weight portion of described each raw material is:
Hirudo: 10-12 Pollen Tyjphae: 12-18 Rhizoma Alismatis: 35-45 Fructus Crataegi: 25-35
Radix Polygoni Multiflori: 15-25 Semen Cassiae: 18-23 Rhizoma Polygoni Cuspidati: 12-13 Radix Salviae Miltiorrhizae: 25-35
Thallus Laminariae (Thallus Eckloniae): 18-22 Sargassum: 18-22 Radix Paeoniae Rubra: 30-35 Rhizoma Chuanxiong: 15-17
Flos Carthami: 8-11.
3. a kind of hyperlipemia, arteriosclerotic Chinese medicine for the treatment of according to claim 1, it is characterized in that: the weight portion of described each raw material is:
Hirudo: 12 Pollen Tyjphae: 15 Rhizoma Alismatis: 40 Fructus Crataegi: 30
Radix Polygoni Multiflori: 20 Semen Cassiaes: 20 Rhizoma Polygoni Cuspidati: 12 Radix Salviae Miltiorrhizaes: 30
Thallus Laminariae (Thallus Eckloniae): 20 Sargassums: 20 Radix Paeoniae Rubra: 30 Rhizoma Chuanxiongs: 20
Flos Carthami: 10.
4. according to claim 1 and 2 or 3 described a kind of hyperlipemia, arteriosclerotic Chinese medicines for the treatment of, it is characterized in that: described medicament is decoction, or is pill, or is electuary, or is capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104160176A CN102961523A (en) | 2012-10-26 | 2012-10-26 | Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104160176A CN102961523A (en) | 2012-10-26 | 2012-10-26 | Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102961523A true CN102961523A (en) | 2013-03-13 |
Family
ID=47792142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104160176A Pending CN102961523A (en) | 2012-10-26 | 2012-10-26 | Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102961523A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106266695A (en) * | 2016-09-05 | 2017-01-04 | 佛山市顺德区宝铜金属科技有限公司 | For treating the medicine of hyperlipemia |
| CN107095981A (en) * | 2017-05-08 | 2017-08-29 | 英山县人民医院 | A kind of Chinese medicine composition for treating phlegm blockage hyperlipemia |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101683462A (en) * | 2008-09-23 | 2010-03-31 | 天津市中宝制药有限公司 | Traditional Chinese medicine composition for coursing the liver and tonifying kidney |
| CN102335398A (en) * | 2011-10-19 | 2012-02-01 | 成都绿迪科技有限公司 | Traditional Chinese medicine formula for treating hyperlipidemia |
-
2012
- 2012-10-26 CN CN2012104160176A patent/CN102961523A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101683462A (en) * | 2008-09-23 | 2010-03-31 | 天津市中宝制药有限公司 | Traditional Chinese medicine composition for coursing the liver and tonifying kidney |
| CN102335398A (en) * | 2011-10-19 | 2012-02-01 | 成都绿迪科技有限公司 | Traditional Chinese medicine formula for treating hyperlipidemia |
Non-Patent Citations (6)
| Title |
|---|
| 《中国民族民间医药》 20110930 陈晨等 高脂血症的从 "肾"论治 11-13 1-4 , 第9期 * |
| 史大卓等: "活血化瘀方药防治动脉粥样硬化概况", 《中医杂志》 * |
| 张保亭: "抗动脉粥样硬化中药的研究进展", 《中国中西医结合杂志》 * |
| 李玉峰等: "赤丹通脉胶囊治疗瘀血阻滞型高脂血症临床观察", 《陕西中医学院学报》 * |
| 楼锦英: "中药降脂研究现状", 《浙江中医学院学报》 * |
| 陈晨等: "高脂血症的从 "肾"论治", 《中国民族民间医药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106266695A (en) * | 2016-09-05 | 2017-01-04 | 佛山市顺德区宝铜金属科技有限公司 | For treating the medicine of hyperlipemia |
| CN107095981A (en) * | 2017-05-08 | 2017-08-29 | 英山县人民医院 | A kind of Chinese medicine composition for treating phlegm blockage hyperlipemia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022021636A1 (en) | Traditional chinese medicine composition for invigorating spleen and activating collaterals, and use thereof | |
| WO2022021639A1 (en) | Traditional chinese medicine composition for invigorating spleen and activating yang, and use thereof | |
| CN103479691B (en) | Fat-reducing liver-protecting Chinese medicine composition | |
| CN102462834A (en) | Medicinal composition for controlling blood sugar of diabetic | |
| CN1558768A (en) | A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof | |
| CN102961523A (en) | Traditional Chinese medicine for treating hyperlipidemia and arteriosclerosis | |
| CN102423382A (en) | Chinese medicine composition for treating dyslipidemia and application thereof | |
| CN102198203B (en) | Traditional Chinese medicine for treating nonalcoholic fatty liver diseases | |
| CN101279034B (en) | Combined Chinese medicament for curing diabetic with combined internal and external therapies and preparation thereof | |
| CN104840871A (en) | Traditional Chinese medicine for treating alcoholic liver injury | |
| CN103142844A (en) | Pharmaceutical composition for treating diabetic nephropathy | |
| CN104306701A (en) | Soup for removing blood stasis and regulating lipid | |
| WO2022021638A1 (en) | Traditional chinese medicinal composition for invigorating spleen and removing turbidity and application thereof | |
| CN102335362B (en) | Traditional Chinese medicine for treating insulin resistance of type 2 diabetes | |
| CN112451618A (en) | Traditional Chinese medicine composition for treating diabetic nephropathy | |
| Tian-zhan et al. | Synergistic effects of Yiqi Huazhuo Gushen herbal formula and valsartan on metabolic syndrome complicated with microalbuminuria | |
| Shao et al. | Recent evidence in support of traditional chinese medicine to restore normal leptin function in simple obesity | |
| CN102824482A (en) | Traditional Chinese medicine composition for treating icteric hepatitis | |
| CN109999076A (en) | It is a kind of adjust reverse cholesterol transport Chinese medicine composition and its application | |
| CN101884735B (en) | Medicament for treating dyslipidemia and preparation method thereof | |
| CN108403904A (en) | Red stilbene Qinghua particle | |
| CN103720931B (en) | A kind of Chinese medicine composition for the treatment of damp-heat accumulation type fatty liver | |
| CN106075189A (en) | A kind of Chinese medicine of blood fat reducing | |
| CN1178684C (en) | Medicine for treating blood fat abnormal and its preparation method | |
| CN105030917A (en) | Compound preparation for treating alcoholic fatty liver |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130313 |